CRF Receptor Antagonists: Utility in Research and Clinical Practice

E-ISSN： 1875-533x|13|23|2751-2760

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.23, 2006-10, pp. : 2751-2760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-Clinical Evidence that Corticotropin-Releasing Factor (CRF) Receptor Antagonists are Promising Targets for Pharmacological Treatment of Alcoholism

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 77-86

Bentham Science Publishers

Access to resources Recommend Favorite

AMPA receptor agonists, antagonists and modulators: their potential for clinical utility

By Bigge C.F. Nikam S.S.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1099-1114

Informa Healthcare

Access to resources Recommend Favorite

Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date

By Valdez Glenn R.

CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. : 887-896

Adis International

Access to resources Recommend Favorite

Therapeutic potential of CRF receptor antagonists: a gut-brain perspective

By Heinrichs S.C. Taché Y.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 647-659

Informa Healthcare

Access to resources Recommend Favorite

Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF

By Jones D.N.C. Kortekaas R. Hatcher P.D. Middlemiss D.N. White A. Hagan J.J.

European Journal of Pharmacology, Vol. 373, Iss. 2, 1999-06 ,pp. : 141-145

Elsevier

Access to resources Recommend Favorite